Credentials: Identifier: NPI 1528860418
Residency
Medical School
Evaluation of the matrix metalloproteinase 9 (MMP9) inhibitor Andecaliximab as an Anti-invasive therapeutic in Head and neck squamous cell carcinoma
Oral Oncology · 2022
River Hames
1 paper